Toggle navigation
Home
Feed
Channels
Profile
Home
Feed
Channels
Profile
Medspoke's Talks
Medspoke
Medspoke
Journal of Allergy and Clinical Immunology (JACI)
Published October 1, 2026
Scientific Advances from Sharing URECA Data in Collaborative Analyses.
October 2, 2026
Medspoke
Medspoke
JACI: In Practice
Published October 1, 2026
00:00
--:--
Sustained low disease activity during long-term mepolizumab treatment in FIP1L1::PDGFRA-negative ...
October 2, 2026
Share
Sustained low disease activity during long-term mepolizumab treatment in FIP1L1::PDGFRA-negative hypereosinophilic syndrome: a multicenter real-world study.
https://www.medspoke.co/channel_journal?id=803&tap_id=14906
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
Medspoke
Medspoke
Clinical Gastroenterology and Hepatology
Published October 1, 2026
Modern Diagnosis and Management of Acid-Related Disorders.
October 2, 2026
Why are you reporting this TALK?